Seer Inc. Cl A (SEER) News
Filter SEER News Items
SEER News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest SEER News From Around the Web
Below are the latest news stories about SEER INC that investors may wish to consider to help them evaluate SEER as an investment opportunity.
Need To Know: The Consensus Just Cut Its Seer, Inc. (NASDAQ:SEER) Estimates For 2024One thing we could say about the analysts on Seer, Inc. ( NASDAQ:SEER ) - they aren't optimistic, having just made a... |
Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services ForumREDWOOD CITY, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the upcoming Canaccord MedTech, Diagnostics and Digital Health and Services Forum in New York, NY. Seer’s management is scheduled to present on Thursday, November 16th at 1:00 p.m. Eastern Time / 10:00 a.m. Pacific Time. A live webcast of the session will be availabl |
Seer, Inc. (NASDAQ:SEER) Q3 2023 Earnings Call TranscriptSeer, Inc. (NASDAQ:SEER) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good day, and thank you for standing by. Welcome to the Seer Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised […] |
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500Seer technology receives recognition for excellence in the field of proteomicsREDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company was selected as “Proteomics Solution of the Year” in the 2023 BioTech Breakthrough Awards program as well as being named to the 2023 Deloitte Technology Fast 500. “After launching our Proteograph XT Assay Kit this ye |
Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue EstimatesSeer, Inc. (SEER) delivered earnings and revenue surprises of 13.16% and 5.37%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock? |
Seer Inc (SEER) Reports Modest Revenue Growth Amidst Economic HeadwindsQ3 2023 Earnings Highlight Expansion Efforts and Increased Adoption of Proteograph Product Suite |
Seer Reports Third Quarter 2023 Financial ResultsExpanded access to the Proteograph™ Product Suite through the Seer Technology Access Center, new distributors and a new Center of ExcellenceREDWOOD CITY, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the third quarter ended September 30, 2023. Recent Highlights Achieved revenue of $4.2 million for the third quarter of 2023, an increase of 5% over the prior |
Seer Announces Addition of Panome Bio to Centers of Excellence (COE) ProgramPanome Bio adds deep, unbiased proteomics to their proprietary metabolomics platform to deliver innovative multi-omics servicesREDWOOD CITY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that Panome Bio has joined its COE Program. Panome Bio is a metabolomics and proteomics services company that provides biopharma innovators unparalleled access to the biomolecules closest to ph |
Seer to Report Third Quarter 2023 Financial Results on November 7, 2023REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the third quarter of 2023 after market close on Tuesday, November 7, 2023. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s websit |
7 Contrarian Stocks to Buy for the High-Stakes GamblerWith limited options available as the market rotates out of risk-on assets, speculators may try their luck with contrarian stocks to buy. |